Glioblastoma Clinical Trials in Shenzhen, Guangdong
3 recruitingShenzhen, Guangdong, China
Showing 1–3 of 3 trials
Recruiting
Phase 1
Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma
GlioblastomaMalignant GliomaRecurrent Glioblastoma+2 more
Beijing Biotech36 enrolled1 locationNCT07480941
Recruiting
Phase 1Phase 2
A Study of VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma
Glioblastoma
Guangzhou Virotech Pharmaceutical Co., Ltd.42 enrolled11 locationsNCT07093814
Recruiting
Phase 1Phase 2
DLL3 CAR-T Therapy Targeting Brain Tumors
Glioblastoma of Cerebellum
Shenzhen Geno-Immune Medical Institute30 enrolled1 locationNCT07180927